{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:02:11Z","timestamp":1769083331738,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare, Japan","doi-asserted-by":"publisher","award":["25180501"],"award-info":[{"award-number":["25180501"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.biologicals.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T15:16:48Z","timestamp":1482938208000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Reduction of animal suffering in rabies vaccine potency testing by introduction of humane endpoints"],"prefix":"10.1016","volume":"46","author":[{"given":"Mutsuyo","family":"Takayama-Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Kweng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Nakamichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Kakiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Horiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Posadas-Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Kurane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2016.12.007_bib1","first-page":"360","article-title":"The NIH test for potency","author":"Wilbur","year":"1996","journal-title":"Lab Tech Rabies"},{"key":"10.1016\/j.biologicals.2016.12.007_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0166-0934(95)01999-5","article-title":"Virological Methods Rabies vaccine potency control: comparison for antigenicity testing of ELISA systems","volume":"58","author":"Rooijakker","year":"1996","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.biologicals.2016.12.007_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1045-1056(02)00070-2","article-title":"Inactivated rabies vaccine control and release: use of an ELISA method","volume":"31","author":"Fournier-Caruana","year":"2003","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2016.12.007_bib4","first-page":"83","article-title":"Annex 2 Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs. WHO Expert Comm. Biol. Stand. fifty-sixth Report","volume":"941","author":"World Health Organization","year":"2007","journal-title":"Tech Rep Ser"},{"key":"10.1016\/j.biologicals.2016.12.007_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.provac.2011.10.001","article-title":"The international workshop on alternative methods to reduce, refine, and replace the use of animals in vaccine potency and safety testing: introduction and summary","volume":"5","author":"Stokes","year":"2011","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.biologicals.2016.12.007_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.biologicals.2014.04.001","article-title":"Replacing the NIH test for rabies vaccine potency testing: a synopsis of drivers and barriers","volume":"42","author":"Schiffelers","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2016.12.007_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.provac.2011.10.003","article-title":"Improving animal welfare and reducing animal use for human vaccine potency testing: state of the science and future directions","volume":"5","author":"Casey","year":"2011","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.biologicals.2016.12.007_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biologicals.2012.07.005","article-title":"Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward","volume":"40","author":"Stokes","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2016.12.007_bib9","first-page":"40","article-title":"Klinische Endpunkte als Ersatz fiir die Bestimmung der Letalitatsrate bei Tollwutinfektionsversuchen zur Impfstoffpriifung-Humane endpoints as a replacement for the estimation of lethality rates in the potency testing of rabies vaccines-","volume":"15","author":"Cussler","year":"1998","journal-title":"Altern Zu Tierexp"},{"key":"10.1016\/j.biologicals.2016.12.007_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/026119290303100409","article-title":"Three Rs approaches in the quality control of inactivated rabies vaccines. The report and recommendations of ECVAM workshop 48","volume":"31","author":"Bruckner","year":"2003","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.biologicals.2016.12.007_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4049\/jimmunol.64.3.185","article-title":"Studies on chick-embryo adapted rabies virus. II. Pathogenicity for dogs and use of egg-adapted strains for vaccination purposes","volume":"64","author":"Koprowski","year":"1950","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2016.12.007_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3181\/00379727-98-23997","article-title":"Growth of rabies virus in non-nervous tissue culture","volume":"98","author":"Kissling","year":"1958","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.biologicals.2016.12.007_bib13","series-title":"Miminimam Requirement of Biological Products","author":"Ministry of Health, Labour and Welfare, Japanese Goverment","year":"2004"},{"key":"10.1016\/j.biologicals.2016.12.007_bib14","first-page":"493","article-title":"Hugo Muench. A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"10.1016\/j.biologicals.2016.12.007_bib15","series-title":"CCAC guidelines on: euthanasia of animals used in science","author":"Canadian Council on Animal Care (CCAC)","year":"2010"},{"key":"10.1016\/j.biologicals.2016.12.007_bib16","series-title":"The Principles of humane experimental Technique","author":"Russell","year":"1959"},{"key":"10.1016\/j.biologicals.2016.12.007_bib17","first-page":"699","article-title":"Rabies vaccine for human use prepared in cell cultures","volume":"0216","author":"European Pharmacopoeia","year":"2005","journal-title":"Monogr"},{"key":"10.1016\/j.biologicals.2016.12.007_bib18","article-title":"Rabies veterinary vaccine, inactivated","volume":"0451","author":"British Phamacopoeia","year":"2012","journal-title":"Monogr"},{"key":"10.1016\/j.biologicals.2016.12.007_bib19","series-title":"WHO expert committee on biological standarization fifty-sixth report","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.biologicals.2016.12.007_bib20","article-title":"Humane endpoints for laboratory animals used in regulatory testing","volume":"43","author":"Stokes","year":"2002","journal-title":"ILAR J"},{"key":"10.1016\/j.biologicals.2016.12.007_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/ilar.41.2.80","article-title":"A\u00a0systematic approach for establishing humane endpoints","volume":"41","author":"Morton","year":"2000","journal-title":"ILAR J"},{"key":"10.1016\/j.biologicals.2016.12.007_bib22","series-title":"Hum. Endpoints anim. Exp. Biomed. Res., London (UK)","first-page":"95","article-title":"Humane endpoints in vaccine research and quality control","author":"Cussler","year":"1999"},{"key":"10.1016\/j.biologicals.2016.12.007_bib23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1258\/002367707782314300","article-title":"Refinement of a transplantation project in the non-human primate by the use of a humane endpoint","volume":"41","author":"Fante","year":"2007","journal-title":"Lab Anim"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105616301671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105616301671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:56:23Z","timestamp":1749855383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105616301671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":23,"alternative-id":["S1045105616301671"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2016.12.007","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of animal suffering in rabies vaccine potency testing by introduction of humane endpoints","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}